Polar Asset Management Partners’s Revolution Medicines RVMD Stock Holding History

Polar Asset Management Partners’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,600	Closed	-$1.51M	–	706
2024 Q4	$1.51M	Buy	34,600 +10,900	+46%	+$550K	0.02%	389
2024 Q3	$1.07M	Buy	23,700 +4,200	+22%	+$183K	0.02%	407
2024 Q2	$757K	Buy	+19,500	New	+$729K	0.02%	414
2023 Q3	–	Sell	-259,700	Closed	-$6.95M	–	959
2023 Q2	$6.95M	Sell	259,700 -20,300	-7%	-$498K	0.12%	210
2023 Q1	$6.06M	Buy	280,000 +109,100	+64%	+$2.69M	0.09%	298
2022 Q4	$4.07M	Sell	170,900 -45,100	-21%	-$959K	0.05%	485
2022 Q3	$4.26M	Sell	216,000 -133,500	-38%	-$2.93M	0.05%	530
2022 Q2	$6.81M	Buy	+349,500	New	+$6.8M	0.08%	378

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Asset Management Partners's RVMD Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Revolution Medicines (RVMD) in Q1 2025, closing a stake of 34,600 shares — an estimated $1.51M sold.

Polar Asset Management Partners first reported a position in RVMD in Q2 2022 and held it in 8 quarters. The position peaked at $6.95M in Q2 2023. 284 funds tracked by Wall St. Rank hold RVMD as of Q1 2025.

Polar Asset Management Partners reported no remaining Revolution Medicines position as of Q1 2025 after selling out during the quarter.
Polar Asset Management Partners sold 34,600 Revolution Medicines shares in Q1 2025, an estimated $1.51M.
Polar Asset Management Partners first reported a position in Revolution Medicines in Q2 2022 and held it in 8 quarters.
Polar Asset Management Partners's Revolution Medicines position peaked at $6.95M in Q2 2023.
284 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.